journal article·2019-12-26Open access

Biphasic Hydrogels Integrating Mineralized and Anisotropic Features for Interfacial Tissue Engineering

Mari Carmen Echave, Rui M. A. Domingues, Manuel Gómez-Florit, José Luis Pedraz, Rui L. Reis, Gorka Orive, Manuela E. Gomes

ACS Applied Materials & Interfaces· Volume 11· Issue 51

Abstract

The innate graded structural and compositional profile of musculoskeletal tissue interfaces is disrupted and replaced by fibrotic tissue in the context of disease and degeneration. Tissue engineering strategies focused on the restoration of the transitional complexity found in those junctions present special relevance for regenerative medicine. Herein, we developed a gelatin-based multiphasic hydrogel system, where sections with distinct composition and microstructure were integrated in a single unit. In each phase, hydroxyapatite particles or cellulose nanocrystals (CNC) were incorporated into an enzymatically cross-linked gelatin network to mimic bone or tendon tissue, respectively. Stiffer hydrogels were produced with the incorporation of mineralized particles, and magnetic alignment of CNC resulted in anisotropic structure formation. The evaluation of the biological commitment with human adipose-derived stem cells toward the tendon-to-bone interface revealed an aligned cell growth and higher synthesis and deposition of tenascin in the anisotropic phase, while the activity of the secreted alkaline phosphatase and the expression of osteopontin were induced in the mineralized phase. These results highlight the potential versatility offered by gelatin-transglutaminase enzyme tandem for the development of strategies that mimic the graded, composite, and complex intersections of the connective tissues.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain

Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz 01006, Spain

3B’s Research Group, I3Bs−Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal

ICVS/3B’s−PT Government Associate Laboratory, Braga/Guimarães, Portugal

The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, Barco, 4805-017 Guimarães, Portugal

University Institute for Regenerative Medicine and Oral Implantology-UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria 01006, Spain

Funding

European Commission · Funda????o para a Ci??ncia e a Tecnologia

References (60)

Show source-provided references
1. 10.1146/annurev-bioeng-062117-12111310.1146/annurev-bioeng-062117-121113 ↗
2. 10.1016/j.addr.2015.03.00410.1016/j.addr.2015.03.004 ↗
3. 10.1115/1.153666010.1115/1.1536660 ↗
4. 10.3109/03008207.2015.108986610.3109/03008207.2015.1089866 ↗
5. 10.3390/ma1211182410.3390/ma12111824 ↗
6. 10.1177/204173141876828510.1177/2041731418768285 ↗
7. 10.1016/j.biomaterials.2011.10.06710.1016/j.biomaterials.2011.10.067 ↗
8. 10.1021/acsami.8b2125910.1021/acsami.8b21259 ↗
9. 10.1021/acsbiomaterials.8b0117910.1021/acsbiomaterials.8b01179 ↗
10. 10.3390/gels501001710.3390/gels5010017 ↗
11. 10.2174/092986732466617051112310110.2174/0929867324666170511123101 ↗
12. 10.1021/acsami.9b0015410.1021/acsami.9b00154 ↗
13. 10.1002/term.181310.1002/term.1813 ↗
14. 10.1002/cbin.1014310.1002/cbin.10143 ↗
15. 10.1002/anie.20170819610.1002/anie.201708196 ↗
16. 10.1002/adma.20170304510.1002/adma.201703045 ↗
17. 10.1021/bm500524s10.1021/bm500524s ↗
18. 10.1021/ma00042a03210.1021/ma00042a032 ↗
19. 10.1039/C5TB00353A10.1039/C5TB00353A ↗
20. 10.1152/physiol.00036.201610.1152/physiol.00036.2016 ↗
21. 10.1007/s10570-006-9061-410.1007/s10570-006-9061-4 ↗
22. 10.1039/C9NR04355A10.1039/C9NR04355A ↗
23. 10.1021/acsami.9b0461610.1021/acsami.9b04616 ↗
24. 10.1159/00032489210.1159/000324892 ↗
25. 10.1039/c8nr04273j10.1039/c8nr04273j ↗
26. 10.1002/adhm.20190020010.1002/adhm.201900200 ↗
27. 10.1016/j.biomaterials.2012.01.05010.1016/j.biomaterials.2012.01.050 ↗
28. 10.1002/jbm.a.3498310.1002/jbm.a.34983 ↗
29. 10.1021/acsami.8b1143610.1021/acsami.8b11436 ↗
30. 10.1002/adfm.20190131410.1002/adfm.201901314 ↗
31. 10.1016/j.mattod.2018.02.00110.1016/j.mattod.2018.02.001 ↗
32. 10.1021/acs.macromol.5b0220110.1021/acs.macromol.5b02201 ↗
33. 10.1016/s0065-3233(08)60217-x10.1016/s0065-3233(08)60217-x ↗
34. 10.1016/j.msec.2016.05.10810.1016/j.msec.2016.05.108 ↗
35. 10.1007/s10616-015-9895-410.1007/s10616-015-9895-4 ↗
36. 10.1021/acs.langmuir.6b0182710.1021/acs.langmuir.6b01827 ↗
37. 10.1021/la404977t10.1021/la404977t ↗
38. 10.1021/acs.nanolett.7b0360010.1021/acs.nanolett.7b03600 ↗
39. 10.1002/smll.20170220710.1002/smll.201702207 ↗
40. 10.1021/acs.biomac.6b0114810.1021/acs.biomac.6b01148 ↗
41. 10.1002/mabi.20180007910.1002/mabi.201800079 ↗
42. 10.1002/adhm.20150035110.1002/adhm.201500351 ↗
43. 10.1007/s13770-018-0169-z10.1007/s13770-018-0169-z ↗
44. 10.1371/journal.pone.008373410.1371/journal.pone.0083734 ↗
45. 10.3390/nano708021910.3390/nano7080219 ↗
46. 10.1016/j.cell.2006.06.04410.1016/j.cell.2006.06.044 ↗
47. 10.1089/ten.TEA.2012.056310.1089/ten.TEA.2012.0563 ↗
48. 10.1016/j.msec.2019.01.06110.1016/j.msec.2019.01.061 ↗
49. 10.11138/mltj/2014.4.3.33310.11138/mltj/2014.4.3.333 ↗
50. 10.1089/ten.TEA.2016.046010.1089/ten.TEA.2016.0460 ↗
51. 10.1039/C8RA00340H10.1039/C8RA00340H ↗
52. 10.1002/adhm.20150070710.1002/adhm.201500707 ↗
53. 10.1002/adfm.20180414810.1002/adfm.201804148 ↗
54. 10.1039/C4TB01073F10.1039/C4TB01073F ↗
55. 10.1002/adma.20150395010.1002/adma.201503950 ↗
56. 10.1021/acs.nanolett.6b0013110.1021/acs.nanolett.6b00131 ↗
57. 10.1021/acsami.6b0390810.1021/acsami.6b03908 ↗
58. 10.1016/j.actbio.2018.03.01710.1016/j.actbio.2018.03.017 ↗
59. 10.1002/adhm.20160003410.1002/adhm.201600034 ↗
60. 10.1002/jbm.a.3327110.1002/jbm.a.33271 ↗